王晖
王晖
弘晖资本 管理及创始合伙人
原鼎晖创投高级合伙人,投资委员会委员。王晖先生前后积累了十多年的国内外的医疗卫生行业经验和投资经验。在加入鼎晖之前,曾就职于美国Avenue Capital和Lehman Brother伦敦分行,并且曾在美国Becton Dickinson 医疗集团全球总部三次提升至收购兼并部高级经理。在这十多年间,王晖先生负责涉及总额超过15亿美金的多项交易,包括收购兼并、上市公司重组、成长型投资及早期投资。  
其主要投资案例包括:康弘药业(002773)、康宁医院(HK.02120)、新世纪儿童医院(HK.01518)、鱼跃医疗(002223)、新眼光(430140)、林华医疗(835637)、合全药业(832159)、普利制药(300630)、药明康德(WUXI)、康龙化成、迈瑞医疗、中和药业、安琪儿妇产医院、马泷齿科、伊美尔整形美容医院、京颐股份、健麾股份等。  

Steven Wang
Managing and Founding Partner HighLight Capital
Mr. Steven Wang is former senior partner and investment committee member of CDH.  He has more than 10 years of experience in the medical industry and healthcare investment and focuses exclusively on healthcare services, medical device and pharmaceutical sectors.  Prior to CDH, Mr. Wang served at Avenue Capital, Lehman Brothers (London) and Becton Dickinson Group.  Over the last ten years, Mr. Wang was responsible for transactions totaling more than 1.5 billion dollars, including mergers & acquisitions, restructuring of publicly listed companies, growth and early stage investments.  
Some of Mr. Wang's representative deals include Kanghong Pharm (002773), KangNing Hospital (HK.02120), Poly(300630), New Century Hospital(HK.01518), New Eyes (430140), Yuwell (002223), Syn The All Pharmaceutical(832159), Linwha(835637), WuXi AppTec, Phamaron, Mindray, Angel’s Women and Children Hospital, New Century, Malo Clinic, Quyiyuan (quyiyuan.com), Dr. Cuiyutao ,KYEE, General Healthy etc.